Review
. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since ExposureAffiliations
AffiliationsItem in Clipboard
Review
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since ExposureLauren M Kucirka et al. Ann Intern Med. 2020.
. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13. AffiliationsItem in Clipboard
AbstractBackground: Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to rule out infection among high-risk persons, such as exposed inpatients and health care workers. It is critical to understand how the predictive value of the test varies with time from exposure and symptom onset to avoid being falsely reassured by negative test results.
Objective: To estimate the false-negative rate by day since infection.
Design: Literature review and pooled analysis.
Setting: 7 previously published studies providing data on RT-PCR performance by time since symptom onset or SARS-CoV-2 exposure using samples from the upper respiratory tract (n = 1330).
Patients: A mix of inpatients and outpatients with SARS-CoV-2 infection.
Measurements: A Bayesian hierarchical model was fitted to estimate the false-negative rate by day since exposure and symptom onset.
Results: Over the 4 days of infection before the typical time of symptom onset (day 5), the probability of a false-negative result in an infected person decreases from 100% (95% CI, 100% to 100%) on day 1 to 67% (CI, 27% to 94%) on day 4. On the day of symptom onset, the median false-negative rate was 38% (CI, 18% to 65%). This decreased to 20% (CI, 12% to 30%) on day 8 (3 days after symptom onset) then began to increase again, from 21% (CI, 13% to 31%) on day 9 to 66% (CI, 54% to 77%) on day 21.
Limitation: Imprecise estimates due to heterogeneity in the design of studies on which results were based.
Conclusion: Care must be taken in interpreting RT-PCR tests for SARS-CoV-2 infection-particularly early in the course of infection-when using these results as a basis for removing precautions intended to prevent onward transmission. If clinical suspicion is high, infection should not be ruled out on the basis of RT-PCR alone, and the clinical and epidemiologic situation should be carefully considered.
Primary funding source: National Institute of Allergy and Infectious Diseases, Johns Hopkins Health System, and U.S. Centers for Disease Control and Prevention.
FiguresFigure 1.
Sensitivity of RT-PCR tests, by…
Figure 1.
Sensitivity of RT-PCR tests, by study and days since symptom onset, for nasopharyngeal…
Figure 1.Sensitivity of RT-PCR tests, by study and days since symptom onset, for nasopharyngeal samples (left), oropharyngeal samples (middle), and unspecified upper respiratory tract (right). RT-PCR = reverse transcriptase polymerase chain reaction.
Figure 2.
Probability of having a negative…
Figure 2.
Probability of having a negative RT-PCR test result given SARS-CoV-2 infection ( top…
Figure 2.Probability of having a negative RT-PCR test result given SARS-CoV-2 infection (top) and of being infected with SARS-CoV-2 after a negative RT-PCR test result (bottom), by days since exposure. RT-PCR = reverse transcriptase polymerase chain reaction; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
Figure 3.
Posttest probability of SARS-CoV-2 infection…
Figure 3.
Posttest probability of SARS-CoV-2 infection after a negative RT-PCR result, by pretest probability…
Figure 3.Posttest probability of SARS-CoV-2 infection after a negative RT-PCR result, by pretest probability of infection. RT-PCR = reverse transcriptase polymerase chain reaction; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
Similar articlesMallett S, Allen AJ, Graziadio S, Taylor SA, Sakai NS, Green K, Suklan J, Hyde C, Shinkins B, Zhelev Z, Peters J, Turner PJ, Roberts NW, di Ruffano LF, Wolff R, Whiting P, Winter A, Bhatnagar G, Nicholson BD, Halligan S. Mallett S, et al. BMC Med. 2020 Nov 4;18(1):346. doi: 10.1186/s12916-020-01810-8. BMC Med. 2020. PMID: 33143712 Free PMC article.
Erensoy S. Erensoy S. Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Emadi A, et al. Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, Taylor M, Cunningham J, Davenport C, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Van den Bruel A, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Dinnes J, et al. Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article. Review.
Hellewell J, Russell TW; SAFER Investigators and Field Study Team; Crick COVID-19 Consortium; CMMID COVID-19 working group; Beale R, Kelly G, Houlihan C, Nastouli E, Kucharski AJ. Hellewell J, et al. BMC Med. 2021 Apr 27;19(1):106. doi: 10.1186/s12916-021-01982-x. BMC Med. 2021. PMID: 33902581 Free PMC article.
Ozturk A, Sener MU, Yılmaz A. Ozturk A, et al. J Surg Oncol. 2020 Nov;122(6):1020-1026. doi: 10.1002/jso.26164. Epub 2020 Aug 11. J Surg Oncol. 2020. PMID: 32783207 Free PMC article.
Chau CH, Strope JD, Figg WD. Chau CH, et al. Pharmacotherapy. 2020 Aug;40(8):857-868. doi: 10.1002/phar.2439. Pharmacotherapy. 2020. PMID: 32643218 Free PMC article. Review.
Katende B, Fernández LG, Muhairwe J, Glass TR, Ayakaka I, Labhardt ND, Ruhwald M, de Vos M, Bresser M, Reither K. Katende B, et al. IJID Reg. 2022 Dec;5:163-164. doi: 10.1016/j.ijregi.2022.10.007. Epub 2022 Nov 3. IJID Reg. 2022. PMID: 36345367 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3